Medical therapy for stroke prevention in the older patient: What to do when aspirin isn't enough

L. Creed Pettigrew

Research output: Contribution to journalReview articlepeer-review

Abstract

Stroke is the most common life-threatening neurological disease and is the fourth leading cause of death among adult Canadians. Aspirin is the most frequently prescribed antithrombotic drug to prevent stroke but may not be a suitable choice in older patients who have already had stroke symptoms despite its use, or cannot tolerate its side effects. For these patients, clopidogrel or the combination of low-dose aspirin with extended release (ER) dipyridamole should be considered for prevention of stroke, This review will compare the relative benefits of aspirin, clopidogrel, and low-dose aspirin/ER-dipyridamole in geriatric patients at risk for stroke.

Original languageEnglish
Pages (from-to)15-19
Number of pages5
JournalGeriatrics and Aging
Volume7
Issue number8
StatePublished - Sep 2004

Keywords

  • Aspirin
  • Clopidogrel
  • Dipyridamole
  • Myocardial infarction
  • Stroke

ASJC Scopus subject areas

  • Aging
  • Gerontology
  • Geriatrics and Gerontology

Fingerprint

Dive into the research topics of 'Medical therapy for stroke prevention in the older patient: What to do when aspirin isn't enough'. Together they form a unique fingerprint.

Cite this